An injectable hydrogel based on Bi 2 Se 3 nanosheets and hyaluronic acid for chemo-photothermal synergistic therapy

To resolve poor accumulation caused by systemic administration, injectable and responsive hydrogels are the prospective drug delivery systems for localized tumor treatment, owning to negligible invasiveness and accurate administration. Herein, an injectable hydrogel, based on dopamine (DA) crosslink...

Full description

Saved in:
Bibliographic Details
Published inInternational journal of biological macromolecules Vol. 244; p. 125064
Main Authors Liu, Qingyun, Yang, Li, Wang, Liangliang, Li, Zimu, Yu, Yongkang, Zheng, Yi, Lian, Daizheng, Li, Xianming, Chen, Hongzhong, Mei, Lin, Zeng, Xiaowei, Gao, Nansha
Format Journal Article
LanguageEnglish
Published Netherlands 31.07.2023
Subjects
Doxorubicin - pharmacology
Doxorubicin - therapeutic use
Humans
Hyaluronic Acid
Hydrogels
Nanogels
Neoplasms - drug therapy
Phototherapy
BiSe
Injectable hydrogel
Polydopamine
Hyaluronic acid
Chemo-photothermal therapy
Online AccessGet full text

Cover

More Information
Summary:To resolve poor accumulation caused by systemic administration, injectable and responsive hydrogels are the prospective drug delivery systems for localized tumor treatment, owning to negligible invasiveness and accurate administration. Herein, an injectable hydrogel, based on dopamine (DA) crosslinked hyaluronic acid and Bi Se nanosheets (NSs) loading with doxorubicin (DOX) coated with polydopamine (Bi Se -DOX@PDA), was developed for synergistic chem-photothermal cancer therapy. The ultrathin functional Bi Se -DOX@PDA NSs could be responsive to the weak acidic condition and photothermal effect under NIR laser irradiation, achieving controlled release of DOX. Moreover, nanocomposite hydrogel based on hyaluronic acid matrix could be precisely administrated through intratumoral injection since its injectability and self-healing capacity, remaining at injected sites for at least 12 days. Furthermore, the excellent therapeutics effect of Bi Se -DOX@PDA nanocomposite hydrogel was demonstrated on 4 T1 xenograft tumor with outstanding injectability and negligible systemic side-effect. In short, the construction of Bi Se -DOX@PDA nanocomposite hydrogel paves a prospective path for local treatment of cancers.
ISSN:1879-0003